Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPSEY | NBIX | IONS | ||
| Company | Ipsen Sa ADR | Neurocrine Bioscienc | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 45.0400 | 167.53 | 75.21 | ||
| High | 45.0400 | 168.00 | 75.96 | ||
| Low | 45.0400 | 163.11 | 73.81 | ||
| Latest | 45.0400 | 163.88 | 74.48 | ||
| Change | +1.1900 | -3.47 | -0.65 | ||
| % Change | +2.71% | -2.07% | -0.87% | ||
| Volume | 600 | 1,050,100 | 1,982,000 | ||
| 20-Day Average Volume | 1,545 | 1,240,005 | 1,673,325 | ||
| Previous Close | 43.8500 | 167.35 | 75.13 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.5752 | 157.71 | 75.27 | ||
| 20-Day Raw Stochastic | 23.27% | 71.59% | 35.12% | ||
| 20-Day Relative Strength | 49.18 | 64.82 | 48.06 | ||
| Weighted Alpha | +44.79 | +34.90 | +55.33 | ||
| Today's Opinion | 72% Buy | 88% Buy | 16% Sell | ||
| Previous Opinion | 56% Buy | 88% Buy | Hold | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.35% since 05/27/26 | +3.52% since 05/29/26 | -2.64% since 05/29/26 | ||
| Low | 43.2022 on 06/02/26 | 154.05 on 06/02/26 | 72.02 on 06/03/26 | ||
| High | 45.0400 on 06/04/26 | 169.57 on 06/04/26 | 76.18 on 06/01/26 | ||
| 1-Month | |||||
| %Chg | -8.24% since 04/30/26 | +21.34% since 05/05/26 | -1.02% since 05/05/26 | ||
| Low | 43.2022 on 06/02/26 | 141.96 on 05/06/26 | 71.93 on 05/18/26 | ||
| High | 51.1000 on 05/05/26 | 169.57 on 06/04/26 | 79.19 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | -1.85% since 03/03/26 | +26.41% since 03/05/26 | -0.90% since 03/05/26 | ||
| Low | 43.0900 on 03/23/26 | 125.11 on 03/24/26 | 68.90 on 03/24/26 | ||
| High | 51.1000 on 05/05/26 | 169.57 on 06/04/26 | 79.19 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +28.28% since 12/04/25 | +5.38% since 12/05/25 | -8.81% since 12/05/25 | ||
| Low | 34.3400 on 01/05/26 | 122.14 on 02/12/26 | 68.90 on 03/24/26 | ||
| High | 51.1000 on 05/05/26 | 169.57 on 06/04/26 | 86.74 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,100,020 | 16,827,044 | 12,416,209 | ||
| Shares Outstanding, K | 335,258 | 100,550 | 165,263 | ||
| Annual Sales | 4,445,500,000 | 2,860,500,000 | 943,710,000 | ||
| Annual Net Income | 501,780,000 | 478,600,000 | -381,390,000 | ||
| Last Quarter Sales | N/A | 814,500,000 | 246,090,000 | ||
| Last Quarter Net Income | N/A | 197,900,000 | -92,530,000 | ||
| 60-Month Beta | 0.42 | 0.40 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.94 on 05/05/26 | -0.30 on 04/29/26 | ||
| Earnings Date | 02/12/26 | 07/29/26 | 07/29/26 | ||
| Most Recent Dividend | 0.302 on 06/04/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/04/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.80 | 0.00 | ||